30-Day Outcomes of Simultaneous Sleeve Gastrectomy and Kidney Transplantation: An Analysis from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database
摘要
Obesity limits access to kidney transplantation (KT) and worsens outcomes in patients with end-stage renal disease (ESRD). Sleeve gastrectomy (SG) is increasingly used to facilitate transplant eligibility; however, the safety of simultaneous SG and KT (SG + KT) remains poorly defined at a multi-institutional level. This study evaluates 30-day perioperative outcomes of SG + KT using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database.
MethodsA retrospective analysis of the MBSAQIP database (2020–2023) was performed. Adult patients undergoing SG were identified with simultaneous KT and captured using CPT codes. Demographics, comorbidities, operative characteristics, and 30-day outcomes were compared between SG-only and SG + KT cohorts. Multivariable logistic regression was used to identify independent predictors of serious complications and 30-day mortality.
ResultsAmong 582,860 patients undergoing SG, 22 (0.004%) underwent simultaneous KT. SG + KT patients were older, predominantly male, and had significantly higher rates of diabetes, hypertension, renal insufficiency, and dialysis dependence (all p < 0.001), with similar body mass index compared to SG alone. SG + KT was associated with longer operative time, increased length of stay, and higher rates of bleeding, readmission within 30-days and serious complications (all p ≤ 0.001). Thirty-day mortality was significantly higher following SG + KT (9.1% vs. 0.1%, p < 0.001). On multivariable analysis, simultaneous KT was the strongest independent predictor of serious complications (OR 7.97; 95% CI 2.27–27.93; p = 0.001) and mortality (OR 33.99; 95% CI 3.99–289.03; p = 0.001).
ConclusionSimultaneous sleeve gastrectomy and kidney transplantation is exceedingly rare and associated with markedly increased 30-day morbidity and mortality compared with sleeve gastrectomy alone, highlighting the need for careful patient selection and multidisciplinary risk assessment.